Drug Type CAR-T |
Synonyms- |
Target |
Mechanism FCRL5 inhibitors(Fc receptor-like protein 5 inhibitors), IL-15 inhibitors(Interleukin-15 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Multiple Myeloma | Preclinical | CN | 12 Jan 2024 |